Safety and Tolerability Study of MCI-196

NCT01818687 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

4

Enrollment

INDUSTRY

Sponsor class

Stopped This study has been terminated because of insufficient patient recruitment.

Conditions

Chronic Kidney Disease
Not on Dialysis
Hyperphosphatemia
Paediatric

Interventions

DRUG: colestilan

Sponsor

Tanabe Pharma Corporation